Stock Price Quote

NEULAND LABORATORIES LTD.

NSE : NEULANDLABBSE : 524558ISIN CODE : INE794A01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE1409.750 (0 %)
PREV CLOSE ( ) 1409.75
OPEN PRICE ( ) 1367.80
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 5956
TODAY'S LOW / HIGH ( )1363.25 1470.90
52 WK LOW / HIGH ( )965.85 1875
NSE1422.9014.75 (+1.05 %)
PREV CLOSE( ) 1408.15
OPEN PRICE ( ) 1422.90
BID PRICE (QTY) 1418.00 (2)
OFFER PRICE (QTY) 1422.90 (21)
VOLUME 44
TODAY'S LOW / HIGH( ) 1422.90 1422.90
52 WK LOW / HIGH ( )967 1874
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 07-01 1984
Management Info
Davuluri Rama Mohan Rao - Chairman Davuluri Saharsh Rao - Managing Director
Registered Office

Address 11th Floor (5th Office Level),Phoenix I V Y Building, Plot No.573 A- I I I,Road No. 82, Jubilee Hills,
Hyderabad,
Telangana-500033

Phone 040-67611600 / 67611700

Email neuland@neulandlabs.com

Website www.neulandlabs.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX

NEWS

23Sep Clarification sought from Neuland Lab
The Exchange has sought clarification from Neuland Laboratories Ltd on S..
04Aug Neuland Laboratories informs about new
Neuland Laboratories has informed about newspaper publication for Unaudi..
15Jul Clarification sought from Neuland Lab
The Exchange has sought clarification from Neuland Laboratories Ltd on J..
08Jul Neuland Laboratories informs about ann
Neuland Laboratories has informed that it enclosed the Annual Report for..
22Jun Neuland Laboratories informs about new
Neuland Laboratories has informed that it enclosed copies of Newspaper A..

Financials

in Millions
QTR Jun 22 ANNUAL 22
Net Profit98.4100000000003635.340000000001
Gross Profit 133.34 817.400000000001
Operating Profit 289.91442.7
Net Sales 2211.79510.77

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Procter&Gamble Healt (BSE)
peergroup  4299.95 (2.66%)
M.Cap ( in Cr)6952.90
Sanofi India (BSE)
peergroup  6045.95 (1.01%)
M.Cap ( in Cr)13784.63
JB Chem & Pharma (BSE)
peergroup  2049.75 (1.48%)
M.Cap ( in Cr)15620.22
Gland Pharma (BSE)
peergroup  2159.95 (1.36%)
M.Cap ( in Cr)35095.93
Pfizer (BSE)
peergroup  4425.05 (0.54%)
M.Cap ( in Cr)20135.64

Shareholding Pattern

NON-INSTITUTION 39.94%
PROMOTERS 36.22%
MUTUAL FUNDS/UTI 0.79%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

Mf Holdings

Scheme NameHold(%)
Quant Small Cap Fund(G)0.70

About Neuland Laboratories Ltd.

Neuland Laboratories Ltd. was incorporated in the year 1984. Its today's share price is 1409.75. Its current market capitalisation stands at Rs 1808.69 Cr. In the latest quarter, company has reported Gross Sales of Rs. 9510.77 Cr and Total Income of Rs.9531.53 Cr. The company's management includes Sarada Bhamidipati, Homi Rustam Khusrokhan, Nirmala Murthy, Bharati Rao, Christopher M Cimarusti, Parampally Vasudeva Maiya, Humayun Dhanrajgir, Davuluri Saharsh Rao, Davuluri Sucheth Rao, Davuluri Rama Mohan Rao.

It is listed on the BSE with a BSE Code of 524558 , NSE with an NSE Symbol of NEULANDLAB and ISIN of INE794A01010. It's Registered office is at 11th Floor (5th Office Level),Phoenix I V Y Building, Plot No.573 A- I I I,Road No. 82, Jubilee HillsHyderabad-500033, Telangana. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are KS Aiyar & Co, MSKA & Associates, Walker Chandik & Co LLP, Walker Chandiok & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)